The challenge of ensuring patient access to
affordable medicines has been tackled by the European Parliament. MEPs this
week debated how best to ensure expensive medicines can be given to people who
need them but who may not be able to afford them. The Independent MEP Marian
Harkin says the EU needs to look at ways to fund the development of costly
medicines especially those that are unlikely to be developed by the pharmaceutical
companies.
Out words: it can
Dur: 00:19